UB Paderborn / Katalog / Suche / in CDI

Incidence and relevance of QTc-interval prolongation caused by tyrosine kinase inhibitors

British journal of cancer, 2015-03, Vol.112 (6), p.1011-1016

2015

Link zum Volltext

Verfügbarkeit prüfen

Weekly cisplatin and daily oral etoposide is highly effective in platinum pretreated ovarian cancer

British journal of cancer, 2002-01, Vol.86 (1), p.19-25

2002

Link zum Volltext

Verfügbarkeit prüfen

Chemoimmunotherapy with dacarbazine, cisplatin, interferon-alpha2b and interleukin-2 versus two cycles of dacarbazine followed by chemoimmunotherapy in patients with metastatic melanoma: A randomised phase II study of the European Organization for Research and Treatment of Cancer Melanoma Group

European journal of cancer (1990), 2006-11, Vol.42 (17), p.2991-2995

2006

Link zum Volltext

Verfügbarkeit prüfen

Effect of combination therapy with aminoglutethimide and hydrocortisone on prostate-specific antigen response in metastatic prostate cancer refractory to standard endocrine therapy

Anti-cancer drugs, 2004-10, Vol.15 (9), p.843-847

2004

Link zum Volltext

Verfügbarkeit prüfen

Immunisation of metastatic cancer patients with MAGE-3 protein combined with adjuvant SBAS-2: a clinical report

European journal of cancer (1990), 2003, Vol.39 (1), p.70-77

2003

Link zum Volltext

Verfügbarkeit prüfen

Influence of pegylated interferon-α therapy on plasma levels of citrulline and arginine in melanoma patients

Amino acids, 2007, Vol.32 (1), p.121-126

2007

Link zum Volltext

Verfügbarkeit prüfen

Bleomycin, vincristine, lomustine and dacarbazine (BOLD) in combination with recombinant interferon alpha-2b for metastatic uveal melanoma

European journal of cancer (1990), 2003-05, Vol.39 (8), p.1115-1120

2003

Link zum Volltext

Verfügbarkeit prüfen

Plasma activity of prolyl endopeptidase in relation to psychopathology during immunotherapy with IFN-alpha in patients with renal cell carcinoma

Journal of interferon & cytokine research, 2008-05, Vol.28 (5), p.283

2008

Link zum Volltext

Verfügbarkeit prüfen

Immunochemotherapy with interleukin-2, interferon-α and 5-fluorouracil for progressive metastatic renal cell carcinoma : a multicenter phase II study

British journal of cancer, 2000-02, Vol.82 (4), p.772-776

2000

Link zum Volltext

Verfügbarkeit prüfen

Interferon-α induced Raynaud's syndrome

Annals of oncology, 2000-11, Vol.11 (11), p.1501-1502

2000

Link zum Volltext

Verfügbarkeit prüfen

Intrapleural administration of tumour necrosis factor-alpha (TNFα) in patients with mesothelioma: cytokine patterns and acute-phase protein response

European journal of clinical investigation, 2000-04, Vol.30 (4), p.336-343

2000

Link zum Volltext

Verfügbarkeit prüfen

Docetaxel (Taxotere): an active agent in metastatic urothelial cancer; results of a phase II study in non-chemotherapy-pretreated patients

British journal of cancer, 1998-11, Vol.78 (10), p.1342-1345

1998

Link zum Volltext

Verfügbarkeit prüfen

The Importance of Long-Term Surveillance of Stage IB Melanomas: Unexpectedly Low Survival Subsequent to Recurrence

Value in health, 2014-11, Vol.17 (7), p.A618-A619

2014

Link zum Volltext

Verfügbarkeit prüfen

Phase I Study of Subcutaneously Administered Recombinant Human Interleukin 12 in Patients with Advanced Renal Cell Cancer

Clinical cancer research, 1999-12, Vol.5 (12), p.3983-3989

1999

Link zum Volltext

Verfügbarkeit prüfen

Viewpoint of the Dutch Melanoma Working Group regarding sentinel lymph node biopsy: prognostic but not therapeutic implications

Nederlands tijdschrift voor geneeskunde, 2008-03, Vol.152 (10), p.574

Kruit, W H J

2008

Link zum Volltext

Verfügbarkeit prüfen

The significance of venography in the management of patients with clinically suspected pulmonary embolism

Journal of internal medicine, 1991-10, Vol.230 (4), p.333-339

1991

Link zum Volltext

Verfügbarkeit prüfen

Second-line chemotherapy with long-term low-dose oral etoposide in patients with advanced breast cancer

Breast cancer research and treatment, 1995-05, Vol.34 (2), p.185-189

1995

Link zum Volltext

Verfügbarkeit prüfen

Regulation of ferritin: a specific role for interferon-alpha (IFN-α)? The acute phase response in patients treated with IFN-α-2b

European journal of clinical investigation, 2002-03, Vol.32 (s1), p.79-83

2002

Link zum Volltext

Verfügbarkeit prüfen

Serum activity of prolyl endopeptidase, but not of dipeptidyl peptidase IV, is decreased by immunotherapy with IFN-alpha in high-risk melanoma patients

Journal of interferon & cytokine research, 2004-07, Vol.24 (7), p.411-415

2004

Link zum Volltext

Verfügbarkeit prüfen

Regulation of ferritin: a specific role for interferon-alpha (IFN-alpha)? The acute phase response in patients treated with IFN-alpha-2b

European journal of clinical investigation, 2002-03, Vol.32 Suppl 1, p.79-83

2002

Link zum Volltext

Verfügbarkeit prüfen

Adverse Effect on Bone Marrow Protection of Prechemotherapy Granulocyte Colony-Stimulating Factor Support

JNCI : Journal of the National Cancer Institute, 1996-10, Vol.88 (19), p.1393-1398

1996

Link zum Volltext

Verfügbarkeit prüfen

Influence of pegylated interferon-[alpha] therapy on plasma levels of citrulline and arginine in melanoma patients

Amino acids, 2007-01, Vol.32 (1), p.121

2007

Link zum Volltext

Verfügbarkeit prüfen

Dose efficacy study of two schedules of high-dose bolus administration of interleukin 2 and interferon alpha in metastatic melanoma

British journal of cancer, 1996-09, Vol.74 (6), p.951-955

1996

Link zum Volltext

Verfügbarkeit prüfen

Adoptive immuno-gene therapy of cancer with single chain antibody [scFv(Ig)] gene modified T lymphocytes

Journal of biological regulators and homeostatic agents, 2004-04, Vol.18 (2), p.134

2004

Link zum Volltext

Verfügbarkeit prüfen

The role of possible risk factors for acute and late renal dysfunction after high-dose interleukin-2, interferon α and lymphokine-activated killer cells

Cancer Immunology, Immunotherapy, 1999-09, Vol.48 (6), p.331-335

1999

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Incidence and relevance of QTc-interval prolongation caused by tyrosine kinase inhibitors

Weekly cisplatin and daily oral etoposide is highly effective in platinum pretreated ovarian cancer

Chemoimmunotherapy with dacarbazine, cisplatin, interferon-alpha2b and interleukin-2 versus two cycles of dacarbazine followed by chemoimmunotherapy in patients with metastatic melanoma: A randomised phase II study of the European Organization for Research and Treatment of Cancer Melanoma Group

Effect of combination therapy with aminoglutethimide and hydrocortisone on prostate-specific antigen response in metastatic prostate cancer refractory to standard endocrine therapy

Immunisation of metastatic cancer patients with MAGE-3 protein combined with adjuvant SBAS-2: a clinical report

Influence of pegylated interferon-α therapy on plasma levels of citrulline and arginine in melanoma patients

Bleomycin, vincristine, lomustine and dacarbazine (BOLD) in combination with recombinant interferon alpha-2b for metastatic uveal melanoma

Plasma activity of prolyl endopeptidase in relation to psychopathology during immunotherapy with IFN-alpha in patients with renal cell carcinoma

Immunochemotherapy with interleukin-2, interferon-α and 5-fluorouracil for progressive metastatic renal cell carcinoma : a multicenter phase II study

Interferon-α induced Raynaud's syndrome

Intrapleural administration of tumour necrosis factor-alpha (TNFα) in patients with mesothelioma: cytokine patterns and acute-phase protein response

Docetaxel (Taxotere): an active agent in metastatic urothelial cancer; results of a phase II study in non-chemotherapy-pretreated patients

The Importance of Long-Term Surveillance of Stage IB Melanomas: Unexpectedly Low Survival Subsequent to Recurrence

Phase I Study of Subcutaneously Administered Recombinant Human Interleukin 12 in Patients with Advanced Renal Cell Cancer

Viewpoint of the Dutch Melanoma Working Group regarding sentinel lymph node biopsy: prognostic but not therapeutic implications

The significance of venography in the management of patients with clinically suspected pulmonary embolism

Second-line chemotherapy with long-term low-dose oral etoposide in patients with advanced breast cancer

Regulation of ferritin: a specific role for interferon-alpha (IFN-α)? The acute phase response in patients treated with IFN-α-2b

Serum activity of prolyl endopeptidase, but not of dipeptidyl peptidase IV, is decreased by immunotherapy with IFN-alpha in high-risk melanoma patients

Regulation of ferritin: a specific role for interferon-alpha (IFN-alpha)? The acute phase response in patients treated with IFN-alpha-2b

Adverse Effect on Bone Marrow Protection of Prechemotherapy Granulocyte Colony-Stimulating Factor Support

Influence of pegylated interferon-[alpha] therapy on plasma levels of citrulline and arginine in melanoma patients

Dose efficacy study of two schedules of high-dose bolus administration of interleukin 2 and interferon alpha in metastatic melanoma

Adoptive immuno-gene therapy of cancer with single chain antibody [scFv(Ig)] gene modified T lymphocytes

The role of possible risk factors for acute and late renal dysfunction after high-dose interleukin-2, interferon α and lymphokine-activated killer cells

Suchergebnisse filtern